December 2011

UnitedHealthcare’s VP for oncology says it will take time to come to grips with the cost of chemotherapy, but we have to start now

John Marcille

Costly protease inhibitors work well in many patients, but call for careful monitoring

Thomas Reinke

Although three pilot programs came up short, experts say systems like PROMETHEUS could still succeed — if plan medical directors take an active role

Frank Diamond

We look at a few programs designed to address adherence-related behavioral problems

Carol Milano

Departments

VIEWPOINT
Weighing the risks and benefits of any treatment to decide whether it is worth pursuing takes a kind of knowledge that most in health care lack
Brent C. James, MD
EVIDENCE REVIEW
A summary of the ECRI Institute’s Emerging Technology Evidence Report
LEGISLATION & REGULATION
However, they’ll need to prove it. Powerful interest groups say insurers have little experience with these patients and worry that MCOs will shortchange members.
John Carroll
PLAN WATCH
Healthy Blue Living in Michigan lets employers and members reap the benefits of lifestyle improvement
Frank Diamond
TOMORROW’S MEDICINE
Clinicians can consider this radiotherapy a viable treatment option
Thomas Morrow, MD

Leave a Comment